Christy Kim, Ph.D. Email & Phone Number

Waltham, MA, US

• Responsible for developing, implementing, and actively leading global market development plans for comprehensive genomic profiling (CGP) in oncology for solid tumors
• Develop annual strategic and tactical marketing plans that are aligned with internal and external partners while updating plans based on new opportunities and channel feedback
• Develop positioning, messaging, collateral, and training to educate the salesforce to be able to competitively position our products within the crowded next-generation sequencing (NGS) market
• Continuously monitor competitors to highlight threats, opportunities, and potential market shifts while developing competitive response strategies to effectively counter the competition
• Manage and cultivate external partnerships with collaborators and speakers to drive peer-to-peer education on the value of CGP for pathologists and oncologists

Santa Clara, CA, US

• Build innovative marketing programs and campaigns to build brand awareness and product education for the launch of Resolution ctDx FIRST, a liquid biopsy companion diagnostic for Mirati Therapeutics’ KRAZATI
• Collaborate with internal and external stakeholders to develop product messaging, promotion, and commercialization plans directed towards medical oncologists and biopharma partners
• Manage agency of record to deliver effective product marketing collateral and facilitate promotional review both internally with medical, legal, and regulatory and externally with our channel and biopharma partners
• Competitive intelligence analysis to support product value proposition and new product development to guide optimal business decisions and to stay competitive within the precision medicine landscape
• Worked cross-functionally to create clinical evidence dossiers, medical affair presentations, and MSL training materials to support the reimbursement and adoption of NGS

Austin, Texas, US

• Championed and promoted a circulating tumor DNA (ctDNA) molecular residual disease (MRD) detection assay (Signatera) by creating marketing collateral targeting surgical oncologists and medical oncologists specializing.
• Managed the promotional speaker bureau (over 200 speaking engagements in 1 year) and created speaker decks (branded/unbranded) to facilitate peer-to-peer education on the clinical utility of MRD detection to help.
• Analyzed ongoing clinical and competitor data with scientific and medical affairs to support marketing claims and competitor positioning for the sales team
• Supported the development and execution of the Signatera value proposition, customer positioning, and the end-to-end customer experience by getting insights from advisory boards and interviewing KOLs

Palo Alto, CA, US

• Executed rebranding of Boston Scientific’s acquired microspheres product family (Embozene, Oncozene, Tandem) marketing collateral to comply with Varian’s branding and promotional review committee
• Developed global sales brochures, product sales presentations, technical guides, pocket references, talk-tracks, and clinical evaluation forms as initiatives to empower the sales team and gather market intelligence
• Implemented a regulated content management platform (SoloFire) for regional specific distribution of marketing collateral, sales training, and clinical education material
• Provided technical and clinical on-label support to the field and off-label support to the medical affairs team in disease states including hypervascular tumors, arteriovenous malformations, hepatocellular carcinoma.
• Developed strategic marketing plans for the bland and drug-eluting microspheres by segmenting the addressable market and formulating tactical plans to increase procedural volume and competitive takeaways

Hayward, CA, US

• Executed scientific development through preclinical studies in animal and human models and clinical studies in veterinary medicine (canine oral melanoma) to advance the Nano-Pulse Stimulation (NPS) technology into.
• Analyzed preclinical and clinical data to optimize combination strategies that included toll-like receptor agonists and checkpoint inhibitors to potentiate the immune response associated with antigenic release
• Researched and proposed potential applications of the NPS technology based on its unique mechanism of action- immunogenic cell death, the pathophysiology of relevant disease states, and the market potential
• Collaborated with R&D, preclinical sites, and research institutions to test feasibility of new applications

Latham, New York, US

• Initiated preclinical development for the Oncology/Surgery Global Business Unit (GBU) to establish safety and feasibility in entering strategic markets to expand the ablation technology portfolio especially in.
• Collaborated with R&D, KOLs, and preclinical sites to test feasibility for new product development
• Developed global markets for the product family through marketing programs, disease state awareness, clinical data generation, healthcare economics focus, and proper messaging and positioning

Latham, New York, US

• Developed and executed a global brand strategy to build brand equity for the Oncology/Surgery Global Business Unit
• Launched the Solero Microwave Tissue Ablation (MTA) System through brand development, product launch support, sales training, trade shows, and digital marketing
• Created sales education/training presentations to address HCP concerns and technical issues

Rancho Cordova, California, US

• Developed and validated clinical stem cell applications and their associated protocols for good manufacturing practice (GMP) cellular manufacturing for CAR T-cellular therapies
• Designed and executed customer specific protocols to optimize and commercialize cellular processing systems, microbubble assisted cell sorting technologies, and automated cell washing/thawing systems
• Trained customers, supported customer evaluations, and generated supporting literature for all product lines including user manuals and application notes

Rancho Cordova, California, US

• Developed new products and improved existing product lines, researched and analyzed market conditions identifying key competition, consumer trends, market requirements, and opportunities
• Managed products lines, created product literature, managed beta and pilot studies, supported customers, and maintained key customer relationships and satisfaction
• Executed product marketing plans and campaigns to generate product awareness and demand and supported sales with necessary product knowledge and technical expertise

Rancho Cordova, California, US

• Designed, executed, and validated protocols for cord blood stem cell processing and bioarchiving

Davis, California, US

• Developed a novel in vitro protocol and investigated the molecular mechanisms for directed differentiation of human embryonic stem cells into definitive endoderm by modulating Wnt/β-catenin and FGF signaling
• Analyzed gene expression and promoter activity using Illumina NGS platform, real-time PCR, chromatin immunoprecipitation, and promoter-activated luciferase assays

Davis, California, US

• Investigated the transcriptional regulation of human β-defensin 2 by IL-17A in airway epithelium

Ph.D., Biochemistry And Molecular Biology

B.S. With Honors, Biochemistry And Molecular Biology

Medical Marketing Program